FGL2:在传染病中用于凝血和免疫调节的新点分子
Chaoyang Wang1, He Sun2, Rui Wang3
1Department of Critical Care Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China.
International immunopharmacology
|November 2, 2024
概括
纤维素样蛋白2 (FGL2) 在传染病期间在炎症和凝血反应中起着关键作用. 针对FGL2可能为难以治疗的感染提供新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
- 传染性疾病 传染性疾病
背景情况:
- 传染病引发复杂的免疫反应,包括炎症和凝血.
- 病原体入侵导致内皮激活,凝血级联启动和血栓形成.
- 感染引起的高凝血性会加剧炎症和免疫失调.
研究的目的:
- 审查纤维素样蛋白2 (FGL2) 在传染病中的多方面的作用.
- 阐明FGL2在促凝,促炎和免疫调节过程中的参与.
- 探索FGL2作为治疗难治传染病的潜在治疗点.
主要方法:
- 对传染病中的FGL2现有研究的文献综述.
- 分析FGL2在宿主免疫反应中的机制.
- 关于FGL2对凝血和炎症的影响的综合证据.
主要成果:
- 纤维素样蛋白2 (FGL2) 参与促进感染期间的凝血和炎症.
- 在传染病的背景下,FGL2积极参与免疫调节.
- 证据突出显示FGL2对感染中的高凝血能力的显著贡献.
结论:
- 在传染病中,FGL2表现出复杂的促凝和免疫调节功能.
- FGL2的关键作用表明其作为治疗点的潜力.
- 准FGL2可能会导致新的干预措施来管理严重和持久性感染.
更多相关视频
09:35Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
14.1K
10:10Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
Published on: November 16, 2016
13.6K
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
624
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
624
Antimicrobial Proteins
936
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
936
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Extrinsic and Intrinsic Pathways of Hemostasis
5.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.8K
